PEGylated Proteins Market Set to Reach USD 19.1 Billion by 2031, Driven by Advancements in Drug Delivery: – Market Research Intellect | PR Newswire [Video]

The PEGylated Proteins Market is primarily driven by the growing demand for effective drug delivery systems, particularly in the treatment of chronic diseases such as cancer, hepatitis, and rheumatoid arthritis. PEGylation enhances the stability, solubility, and half-life of therapeutic proteins, leading to better efficacy and fewer side effects. Additionally, advancements in biologics and increasing R&D investments in biotechnology and pharmaceuticals are fueling market growth. The rise in chronic disease prevalence and the need for advanced treatment options further boost the adoption of PEGylated proteins.

, /PRNewswire/ — The PEGylated Proteins Market is projected to grow from approximately USD 12.3 billion in 2024 to USD 19.1 billion by 2031, with a compound annual growth rate (CAGR) of around 6.5%. This growth is driven by the increasing use of PEGylated proteins in drug delivery, particularly for treating chronic diseases such as cancer and rheumatoid arthritis, as well as rising investments in biotechnology and pharmaceuticals.

Download PDF Brochure: https://www.marketresearchintellect.com/download-sample/?rid=222584

202 – Pages

126 – Tables

37 …